Best of Biotech
business plan competition organized by Austria Wirtschaftsservice
Best of Biotech (BOB) is an international business plan competition with focus on life sciences, i.e. Biotechnology, Medical technology and related fields. The competition is organized every 1–2 years by LISA (Life Science Austria), a program run by Austria Wirtschaftsservice, the Austrian federal development and financing bank, to promote entrepreneurship in the life science sector. The competition is co-sponsored by private life science and healthcare companies and is organized in partnership with international tech transfer agencies and business incubators.
History
Since the first contest in 2000, 211 projects teams have participated, 41 companies have been founded and around €170,000 in prize money has been awarded. Among the companies founded are AYOXXA Biosystems, AVIR Green Hills Biotechnology, Oridis Biomed, Protaffin AG and Ugichem.
Competition
The contest is divided into two phases: In the first phase, participants submit a business idea of which the best three are awarded a cash prize. The second phase includes workshops and coaching sessions, which enable the participants to translate their business ideas into professional business plans. The best three business plans as well as the best medical technology business plan are finally awarded cash prizes. The competition is open to participants from all countries.
Begin with the source’s own compact description: “Best of Biotech” is business plan competition organized by Austria Wirtschaftsservice. The dossier treats that line as a proposition to test through Best, Biotech and business, not as a finished interpretation.
Why this record matters
The phrase “business plan competition organized by Austria Wirtschaftsservice” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Dec 26, 2025. The linked authority identifier is Q830330. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2000.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Best of Biotech”, its source revision and the description used here.
- Expand the search: follow Best of Biotech primary sources, Best of Biotech archive and Best research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Best of Biotech”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Best of Biotech” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.